Authors: Wiseman, GA White, CA Sparks, RB Erwin, WD Podoloff, DA Lamonica, D Bartlett, NL Parker, JA Dunn, WL Spies, SM Belanger, R Witzig, TE Leigh, BR

Citation: Ga. Wiseman et al., Biodistribution and dosimetry results from a phase III prospectively randomized controlled trial of Zevalin (TM) radioimmunotherapy for low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma, CR R ONC H, 39(1-2), 2001, pp. 181-194